Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 199 (RNA5SP199) is a member of the large family of ribosomal RNA pseudogenes in the human genome. Unlike functional 5S ribosomal RNA genes that participate in ribosome assembly and protein synthesis, this pseudogene does not produce a functional RNA molecule. Pseudogenes such as RNA5SP199 are generally considered noncoding and nonfunctional, serving as remnants of gene duplication or retrotransposition events that have accumulated mutations disabling their normal expression or function[2][4][6][16]. There is no evidence that RNA5SP199 serves a regulatory, therapeutic, or biomarker role in human biology at this time. ### Additional Notes - **Pseudogenes** like RNA5SP199 are common in the genome and are generally excluded from therapeutic target databases because they do not encode proteins or functional RNAs and typically lack biological activity[2][4][16]. - RNA5SP199 is classified specifically as a ribosomal RNA (rRNA) pseudogene, reflecting its sequence similarity to the functional 5S rRNA gene, but it is inactivated by accumulated mutations[4][6]. - Functional 5S rRNA is a critical structural and functional element of the large ribosomal subunit, but this specific pseudogene (RNA5SP199) does not contribute to ribosome structure or function[1][5][6]. - The presence of "pseudogene" in its canonical name, biotype, and annotations from authoritative databases such as GENCODE/Ensembl and the Alliance of Genome Resources affirms its nonfunctional designation[4][6][7]. This entry should not be considered a therapeutic or functional biological target.
None (not applicable; no drugs target this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 199 (RNA5SP199).